comprise a histologic spectrum, ranging from hyperplastic-appearing lesions to frank non-Hodgkin’s lymphoma or multiple myeloma histology. Multiple clones may coexist, each representing a discrete lymphomagenic event, a situa-tion that is unique to immunodeficiency states. The incidence varies from 1 % in renal recipients to 5 % in heart recipients, but can be markedly increased by the use of anti-T-cell therapies or by T-cell depletion in bone marrow transplan-tation. PTLD continues to arise, even many years after transplantation, and late T-cell lymphomas have recently been recognized. Pretransplant Epstein-Barr virus (EBV) se-ronegativity increases risk to as high as 30%–50%. PTLD has a highly variable clinical picture; certain patterns ...
The posttransplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of neoplasms that...
To study the clinical and histopathologic features, diagnosis, pathogenesis and therapy of post-tran...
PTLD is a rare but severe complication of hematopoietic or solid organ transplant recipients, with v...
Post-transplant lymphoproliferative disorders (PTLDs) occur as a consequence of immunosuppression in...
Post-transplant lymphoproliferative disorders (PTLDs) are lymphoid or plasmacytic proliferations ran...
Introduction Post-transplant lymphoproliferative disorder (PTLD) is a heterogeneous group of disease...
International audiencePost-transplant lymphoproliferative disorders (PTLDs) represent a serious comp...
Posttransplant lymphoproliferative disorder (PTLD) is a serious and still frequently observed (2-15%...
Posttransplant lymphoproliferative disorder (PTLD) is a serious complication of organ transplantatio...
Post-transplant lymphoproliferative disorders (PTLD) are a heterogeneous group of lymphoproliferativ...
Post-Transplant Lymphoproliferative Disorder (PTLD) is a lymphoma, which develops as a result of imm...
Two patients presented with post-transplant lymphoproliferative disorder (PTLD). PTLD encompasses a ...
Background. Posttransplantation lymphoproliferative diseases (PTLD) are mainly Epstein-Barr virus (E...
SummaryPost-transplantation lymphoproliferative disorders (PTLDs) are heterogeneous lymphoid prolife...
Post-transplant lymphoproliferative disorder (PTLD) is a spectrum of major, life-threatening lymphop...
The posttransplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of neoplasms that...
To study the clinical and histopathologic features, diagnosis, pathogenesis and therapy of post-tran...
PTLD is a rare but severe complication of hematopoietic or solid organ transplant recipients, with v...
Post-transplant lymphoproliferative disorders (PTLDs) occur as a consequence of immunosuppression in...
Post-transplant lymphoproliferative disorders (PTLDs) are lymphoid or plasmacytic proliferations ran...
Introduction Post-transplant lymphoproliferative disorder (PTLD) is a heterogeneous group of disease...
International audiencePost-transplant lymphoproliferative disorders (PTLDs) represent a serious comp...
Posttransplant lymphoproliferative disorder (PTLD) is a serious and still frequently observed (2-15%...
Posttransplant lymphoproliferative disorder (PTLD) is a serious complication of organ transplantatio...
Post-transplant lymphoproliferative disorders (PTLD) are a heterogeneous group of lymphoproliferativ...
Post-Transplant Lymphoproliferative Disorder (PTLD) is a lymphoma, which develops as a result of imm...
Two patients presented with post-transplant lymphoproliferative disorder (PTLD). PTLD encompasses a ...
Background. Posttransplantation lymphoproliferative diseases (PTLD) are mainly Epstein-Barr virus (E...
SummaryPost-transplantation lymphoproliferative disorders (PTLDs) are heterogeneous lymphoid prolife...
Post-transplant lymphoproliferative disorder (PTLD) is a spectrum of major, life-threatening lymphop...
The posttransplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of neoplasms that...
To study the clinical and histopathologic features, diagnosis, pathogenesis and therapy of post-tran...
PTLD is a rare but severe complication of hematopoietic or solid organ transplant recipients, with v...